Breaks Categories: News

MondayJul 18, 2022 10:43 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Appoints Michael Woudenberg as Chief Operating Officer

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced its appointment of Michael Woudenberg as chief operating officer of the company, overseeing all day-to-day operations. Woudenberg previously served as senior vice president of chemistry, manufacturing and controls. For the past several years, he has been an integral part of InMed’s executive team, supporting multiple functions within the organization. Prior to joining InMed, Woudenberg had over 20 years of successful drug development, process engineering, GMP manufacturing and general management experience at all levels of various companies. “I would like to congratulate Mike…

Continue Reading

FridayJul 15, 2022 12:59 pm

NetworkNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Unveils Mobile Device Protection Product in China

FingerMotion (NASDAQ: FNGR), a mobile data and services company, has launched a line of new mobile device protection products in China; the products are provided by FingerMotion’s subsidiary, Shanghai TengLian Jiujiu Information and Communication Technology Co. Ltd. (TengLian). The company noted that the distribution of these protection products has already begun, with the first phase of rollout happening in Hunan Province, which has a mobile subscriber base of 90 million; the company is planning phased rollouts in the months that will ultimately reach 1.2 billion subscribers. The products are available as embedded, value-added features on devices offered through Chinese carriers.…

Continue Reading

FridayJul 15, 2022 11:55 am

NetworkNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Moving to Become Top Liquidity Service Provider on Lightning Network

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network, currently has active nodes spanning 17 countries. “LQwD’s mission is to offer platform-as-a-service (‘PaaS’) for the Lightning Network nodes and payment channels, be a network service provider that offers routing and liquidity services, and accumulate Bitcoin as a treasury reserve asset for staking and liquidity. The company’s flagship PaaS offering, https://lqwd.tech/, was released in November 2021. The PaaS features a sophisticated backend functionality and was designed to be scalable and flexible, positioning needed for the growth of the network,”…

Continue Reading

FridayJul 15, 2022 10:45 am

NetworkNewsBreaks – AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) Enters into $14.025M Convertible Debt Facility Agreement

AgriFORCE Growing Systems, an intellectual property (“IP”)-focused agtech company dedicated to advancing sustainable cultivation and crop processing across multiple verticals, announced the company has entered into a definitive agreement for a convertible debt facility. The principal amount is for $14.025 million, subject to a 10% original issue discount, with a potential additional principal amount of $33 million with accredited institutional investors. According to the announcement, AgriFORCE anticipates initially receiving $12.75 million, with the right to receive the additional $33 million in one or more tranches at the discretion of the investors. Those funds would be subject to certain conditions and…

Continue Reading

ThursdayJul 14, 2022 1:06 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Awarded Patent in Japan, Submits Briefing Book

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, announced that it has been notified that it will be awarded a new patent in Japan, which makes the 26th world patent for the company. The patent, which is the third one granted in Japan, recognizes the company’s patented drug-delivery technology, DehydraTECH(TM), and its ability to deliver active pharmaceutical ingredients (“APIs”) more efficiently, regardless of the “food effect,” or the presence of food in the gastrointestinal system. Drug delivery is a key component of reliable drug dosing. According to the announcement, this is the first patent issued from Lexaria’s seventh…

Continue Reading

ThursdayJul 14, 2022 12:19 pm

NetworkNewsBreaks – Lehua Brands, CA State Fair Cannabis Awards to Offer Adult Fairgoers Opportunity to Experience Special Edition TerpTonic Beverages

Lehua Brands is serving as the official beverage of the CA State Fair Cannabis Awards and today announced the special edition TerpTonic beverages in collaboration with four of California’s most acclaimed cannabis cultivators. According to the announcement, the special edition TerpTonic beverages and slushies will be available for purchase (quantities may be limited) at the Lehua Brands booth (#13) within the CA Cannabis Exhibit at the CA State Fair in Expo Center Building One. The cultivators and their award-winning strains include two Golden Bear “Best of California” winners, Esensia Gardens (Buddha’s Hand) and Greenshock Farms (Passion Orange Guava), as well as two Gold Medal winners, Booney Acres (Gelonade) and Emerald Spirit Botanicals (Pink…

Continue Reading

ThursdayJul 14, 2022 11:21 am

NetworkNewsBreaks – Odyssey Health Inc.’s (ODYY) Spokesperson Brett Favre to Be Featured on RedChip Money Report(R)

Odyssey Health (OTC: ODYY), f/k/a Odyssey Group International Inc., will be featured in a new interview aired by RedChip Companies on The RedChip Money Report(R) on Bloomberg TV at 7 p.m. Eastern Time this Saturday, July 16. Bloomberg TV is available in an estimated 73 million homes across the U.S. In the exclusive interview, Odyssey Health’s spokesperson and Pro Football Hall of Fame quarterback Brett Favre discusses the major concussion he sustained in the final play of his professional career. Favre will share why he is proudly working to reduce and prevent concussions, the potential of Odyssey’s concussion treatment, and…

Continue Reading

ThursdayJul 14, 2022 11:13 am

NetworkNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Announces Completion of Partial Interest in Alberta-Based RNG Facility

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has completed the acquisition of a 67% interest in Grow the Energy Circle Ltd. (GrowTEC), a multi-faceted bioenergy venture of sustainable agriculture located in Alberta. Located on the Perry Family farm, GrowTEC integrates responsible best practices and renewable energy. The operating farm-scale biogas facility features an anaerobic digester that converts biodegradable waste into biogas, generating renewable power. With the acquisition now complete, EverGen plans on working with GrowTEC to add on and upgrade the facility; currently the project has an agreement with FortisBC to contribute to its target to…

Continue Reading

ThursdayJul 14, 2022 11:02 am

NetworkNewsBreaks – HIVE Blockchain Technologies Ltd. (TSX.V: HIVE) (NASDAQ: HIVE) (FSE: HBF) Releases Update Regarding Delayed Annual Filings

HIVE Blockchain Technologies (TSX.V: HIVE) (NASDAQ: HIVE) (FSE: HBF) is sharing an update regarding the status of its audited financial statements for the year ended March 31, 2022, as well as its CEO and CFO certifications, and management discussion and analysis for the same period. HIVE reports that the company is working diligently with its auditors to complete the required filings and plans on filing the documents on or before July 18, 2022. According to the update, HIVE notes that there has been “no material change in the information contained in the default announcement issued on June 29, 2022, and there is…

Continue Reading

WednesdayJul 13, 2022 4:10 pm

NetworkNewsBreaks – QSAM Biosciences Inc. (QSAM) Expands IP Estate with Receipt of Third US Patent for CycloSam(R)

QSAM Biosciences (OTCQB: QSAM) is a company developing next-generation targeted therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (“CycloSam(R)”), for the treatment of cancer and related diseases. The company today announced that the United States Patent & Trademark Office has granted a key patent protecting how CycloSam(R) is formulated and prepared, namely by using a nonradioactive kit that can be delivered and stored local to the administration site and provides for high purity in an efficient, facile and reproducible process at lower costs. “This patent issuance marks our third granted patent in the United States and further strengthens our IP estate, consisting of 14…

Continue Reading